Relationship between Arterial Stiffness and Renal Function Determined by Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) Equations in a Chinese Cohort Undergoing Health Examination

Table 4

Determinants of c-fPWV.

Variable	B	β	Se	value	Adjusted R^2
Moldel 1					0.328
(constant)	0.370
Age	0.063	0.378	0.008	<0.01
SBP	0.033	0.278	0.005	<0.01
HR	0.020	0.094	0.009	0.023
CKD-EPICysC	-0.011	-0.110	0.005	0.027
FPG	0.105	0.097	0.045	0.019
Model 2					0.330
(constant)	0.671
Age	0.06	0.347	0.008	<0.01
SBP	0.033	0.275	0.005	<0.01
HR	0.019	0.086	0.009	0.038
CKD-EPICysC	-0.012	-0.118	0.005	0.018
FPG	0.107	0.098	0.045	0.019
Model 3					0.351
(constant)
Age	0.064	0.394	0.008	<0.01
SBP	0.033	0.276	0.005	<0.01
HR	0.017	0.076	0.010	0.073
CKD-EPICysC	-0.010	-0.105	0.005	0.042
FPG	0.093	0.086	0.207	0.051

Model 1: Adjusted for sex, age, SBP, HR, MDRD, CKD-EPI_SCr, CKD-EPI_CysC, CKD-EPI_SCr/CysC, LDL, and FPG. Model 2: adjusted for sex, age, SBP, HR, MDRD, CKD-EPI_SCr, CKD-EPI_CysC, CKD-EPI_SCr/CysC, LDL, FPG, and smoking. Model 3: adjusted for sex, age, SBP, HR, MDRD, CKD-EPI_SCr, CKD-EPI_CysC, CKD-EPI_SCr/CysC, LDL, FPG, smoking, antihypertensive medication, statins, and hypoglycemic agents. SBP: systolic blood pressure; HR: heart rate; LDL-c: low density lipoprotein cholesterol; FPG: fasting blood glucose.